S&P 500   4,443.35 (-0.13%)
DOW   34,724.73 (-0.12%)
QQQ   370.86 (-0.57%)
AAPL   145.99 (-0.57%)
MSFT   297.18 (-0.79%)
FB   347.93 (+0.57%)
GOOGL   2,830.88 (+0.23%)
TSLA   760.64 (+0.93%)
AMZN   3,396.44 (-0.57%)
NVDA   219.01 (-2.58%)
BABA   146.61 (-3.03%)
NIO   35.44 (-1.58%)
CGC   13.97 (-4.05%)
GE   103.96 (+0.97%)
MU   74.30 (+0.35%)
AMD   105.03 (-1.06%)
T   27.17 (-0.07%)
F   13.82 (+0.80%)
ACB   6.01 (-2.28%)
DIS   175.39 (-0.49%)
PFE   44.04 (-0.34%)
BA   220.92 (-0.08%)
BAC   42.18 (+1.18%)
S&P 500   4,443.35 (-0.13%)
DOW   34,724.73 (-0.12%)
QQQ   370.86 (-0.57%)
AAPL   145.99 (-0.57%)
MSFT   297.18 (-0.79%)
FB   347.93 (+0.57%)
GOOGL   2,830.88 (+0.23%)
TSLA   760.64 (+0.93%)
AMZN   3,396.44 (-0.57%)
NVDA   219.01 (-2.58%)
BABA   146.61 (-3.03%)
NIO   35.44 (-1.58%)
CGC   13.97 (-4.05%)
GE   103.96 (+0.97%)
MU   74.30 (+0.35%)
AMD   105.03 (-1.06%)
T   27.17 (-0.07%)
F   13.82 (+0.80%)
ACB   6.01 (-2.28%)
DIS   175.39 (-0.49%)
PFE   44.04 (-0.34%)
BA   220.92 (-0.08%)
BAC   42.18 (+1.18%)
S&P 500   4,443.35 (-0.13%)
DOW   34,724.73 (-0.12%)
QQQ   370.86 (-0.57%)
AAPL   145.99 (-0.57%)
MSFT   297.18 (-0.79%)
FB   347.93 (+0.57%)
GOOGL   2,830.88 (+0.23%)
TSLA   760.64 (+0.93%)
AMZN   3,396.44 (-0.57%)
NVDA   219.01 (-2.58%)
BABA   146.61 (-3.03%)
NIO   35.44 (-1.58%)
CGC   13.97 (-4.05%)
GE   103.96 (+0.97%)
MU   74.30 (+0.35%)
AMD   105.03 (-1.06%)
T   27.17 (-0.07%)
F   13.82 (+0.80%)
ACB   6.01 (-2.28%)
DIS   175.39 (-0.49%)
PFE   44.04 (-0.34%)
BA   220.92 (-0.08%)
BAC   42.18 (+1.18%)
S&P 500   4,443.35 (-0.13%)
DOW   34,724.73 (-0.12%)
QQQ   370.86 (-0.57%)
AAPL   145.99 (-0.57%)
MSFT   297.18 (-0.79%)
FB   347.93 (+0.57%)
GOOGL   2,830.88 (+0.23%)
TSLA   760.64 (+0.93%)
AMZN   3,396.44 (-0.57%)
NVDA   219.01 (-2.58%)
BABA   146.61 (-3.03%)
NIO   35.44 (-1.58%)
CGC   13.97 (-4.05%)
GE   103.96 (+0.97%)
MU   74.30 (+0.35%)
AMD   105.03 (-1.06%)
T   27.17 (-0.07%)
F   13.82 (+0.80%)
ACB   6.01 (-2.28%)
DIS   175.39 (-0.49%)
PFE   44.04 (-0.34%)
BA   220.92 (-0.08%)
BAC   42.18 (+1.18%)
ASX:ALC

Alcidion Group Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.21 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive ALC News and Ratings via Email

Sign-up to receive the latest news and ratings for Alcidion Group and its competitors with MarketBeat's FREE daily newsletter.


About Alcidion Group

Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision that combines artificial intelligence, clinical decision support, and mobile alerts in clinical dashboard; Patientrack, a patient safety and communication system; and Smartpage, a messaging and task management platform, which enables hospital staff to communicate and collaborate. It also provides project management, data and analytics, implementation consulting, and integration and support services for digital health projects. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. The company was founded in 2000 and is headquartered in South Yarra, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Alcidion Group (ASX:ALC) Frequently Asked Questions

What stocks does MarketBeat like better than Alcidion Group?

Wall Street analysts have given Alcidion Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Alcidion Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Alcidion Group's key executives?

Alcidion Group's management team includes the following people:
  • Ms. Kate Quirke, MD, CEO & Exec. Director
  • Mr. Raymond Howard Blight, Co-Founder & Non-Exec. Director
  • Mr. Colin Bruce MacKinnon, Chief Operating Officer
  • Prof. Malcolm Pradhan, Chief Medical Officer, Product Mang. & Exec. Director
  • Mr. Matthew Gepp, Chief Financial Officer
  • Ms. Tracey Harvey, HR Mang.
  • Ms. Melanie Jaye Leydin C.A., B.Bus, CA, Company Sec. (Age 48)

What other stocks do shareholders of Alcidion Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcidion Group investors own include Cronos Group (CRON), Deere & Company (DE), GrowGeneration (GRWG), Immunomedics (IMMU), NAOS Emerging Opportunities (NCC), Novartis (NVS), Teck Resources (TECK), Ability (ABIL), AbbVie (ABBV) and Axon Enterprise (AAXN).

What is Alcidion Group's stock symbol?

Alcidion Group trades on the ASX under the ticker symbol "ALC."

How much money does Alcidion Group make?

Alcidion Group has a market capitalization of $0.00 and generates $25.88 million in revenue each year.

How many employees does Alcidion Group have?

Alcidion Group employs 20,000 workers across the globe.

What is Alcidion Group's official website?

The official website for Alcidion Group is www.alcidion.com.

Where are Alcidion Group's headquarters?

Alcidion Group is headquartered at rue Louis-d'Affry 6, Fribourg, 1701.

How can I contact Alcidion Group?

Alcidion Group's mailing address is rue Louis-d'Affry 6, Fribourg, 1701. The company can be reached via phone at 61 8 6489 1600.


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.